Wholesalers sheltered from pharmacy suits by "sharing agreement" with manufacturers.
Executive Summary
WHOLESALERS ARE SHELTERED FROM PHARMACY PRICE DISCRIMINATION SUITS under a series of agreements with drug manufacturers to cover the upfront legal costs and any settlement fees associated with the multitude of antitrust actions filed by pharmacies since mid-1993. The "judgment sharing agreement" between six wholesalers and 26 pharmaceutical manufacturers is outlined in recently-released financial reports from Bergen Brunswig, AmeriSource and FoxMeyer Health.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth